Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Endosc. Sep 16, 2021; 13(9): 391-406
Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.391
Table 5 The results of multivariate analysis showing the predictors of gastrointestinal hemorrhage in a population of patients with gastrointestinal cancer
Predictors of GI hemorrhage

aOR
95%CI
P value
Demographic factors
Age (yr)1.01(1.01-1.02)< 0.001
Female0.84(0.81-0.86)< 0.001
RaceWhite- Reference1.00--
Black1.27(1.22-1.31)< 0.001
Hispanic1.19(1.14-1.24)< 0.001
Asian or Pacific Islander1.42(1.34-1.50)< 0.001
Native American1.24(1.06-1.46)0.007
Other1.13(1.05-1.21)0.001
Socioeconomic factors
InsuranceMedicare- Reference1.00--
Medicaid1.17(1.12-1.22)< 0.001
Private0.91(0.88-0.94)< 0.001
Self-pay1.44(1.34-1.56)< 0.001
No charge1.21(0.94-1.56)0.148
Other1.03(0.95-1.12)0.468
Median household income for patient ZIP Code1st quartile- Reference1.00--
2nd quartile0.98(0.95-1.01)0.246
3rd quartile0.96(0.93-0.99)0.022
4th quartile0.94(0.90-0.97)< 0.001
Comorbidities
Acute kidney injury1.17(1.13-1.20)< 0.001
Chronic kidney disease1.22(1.18-1.26)< 0.001
Heart failure1.19(1.12-1.27)< 0.001
Cirrhosis and liver failure1.84(1.78-1.90)< 0.001
Cancer related
Metastasis0.93(0.90-0.95)< 0.001
Chemo and Immunotherapy0.74(0.72-0.77)< 0.001
Radiation gastroenteritis/proctitis2.39(2.02-2.81)< 0.001
Palliative care1.21(1.17-1.26)< 0.001
Nutritional status
Severe malnutrition and cachexia1.12(1.08-1.15)< 0.001
Obesity0.94(0.90-0.98)0.001
Use of antithrombotic/anticoagulants
Aspirin/antiplatelets1.09(1.05-1.13)< 0.001
Anticoagulants1.48(1.42-1.54)< 0.001